Funding
Turn ideas into impact
Show Me
Due: May 7, 2026
NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-166
Due: May 7, 2026
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-063
Due: May 7, 2026
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-111
Due: May 7, 2026
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-23-059
Due: May 7, 2026
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-110
Due: May 7, 2026
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
US $200,000
Type
Grant
Source
Federal
Opp Number
PAS-25-102
Due: May 7, 2026
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-239
Due: May 7, 2026
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-036
Due: May 7, 2026
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-254
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?